Prediction of COVID-19 Mortality in Patients with Cancer

por Mantha, Simon, Jee, Justin, Soff, Gerald A., Pessin, Melissa S.
Publicado 2020

Maternal administration of anti-angiogenic agents, TNP-470 and Angiostatin(4.5), induces fetal microphthalmia

por Rutland, Catrin S., Jiang, Keyi, Soff, Gerald A., Mitchell, Christopher A.
Publicado 2009

Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study

por Mantha, Simon, Miao, Yimei, Wills, Jonathan, Parameswaran, Rekha, Soff, Gerald A.
Publicado 2017

Treatment of central venous catheter‐associated deep venous thrombosis in cancer patients with rivaroxaban

por Laube, Eva S., Mantha, Simon, Samedy, Patrick, Wills, Jonathan, Harnicar, Stephen, Soff, Gerald A.
Publicado 2016

The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies

por Shaw, Jaime L., Nielson, Carrie M., Park, Joseph K., Marongiu, Andrea, Soff, Gerald A.
Publicado 2021

Implementing a Clinical Decision Tool to Improve Oncologic Venous Thromboembolism Management

por Majeed, Jibran, Turner, Barbara S., Kelly, Deirdre, Poon, Chester, Thompson, Julie A., Barrett, John, Soff, Gerald A.
Publicado 2022

A tumor-selective adenoviral vector platform induces transient antiphospholipid antibodies, without increased risk of thrombosis, in phase 1 clinical studies

por Khalil, Danny N., Prieto González-Albo, Isabel, Rosen, Lee, Lillie, Tom, Stacey, Andrea, Parfitt, Lola, Soff, Gerald A.
Publicado 2023

Romiplostim for chemotherapy‐induced thrombocytopenia: Efficacy and safety of extended use

por Wilkins, Cy R., Ortiz, Jocelyn, Gilbert, Leah J., Yin, Shen, Mones, Jodi V., Parameswaran, Rekha, Mantha, Simon, Soff, Gerald A.
Publicado 2022

Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia

por Soff, Gerald A., Ray-Coquard, Isabelle, Rivera, Luis J. Marfil, Fryzek, Jon, Mullins, Megan, Bylsma, Lauren C., Park, Joseph K.
Publicado 2022

Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study

por Mantha, Simon, Laube, Eva, Miao, Yimei, Sarasohn, Debra M., Parameswaran, Rekha, Stefanik, Samantha, Brar, Gagandeep, Samedy, Patrick, Wills, Jonathan, Harnicar, Stephen, Soff, Gerald A.
Publicado 2016

Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial

por Khorana, Alok A., McNamara, Mairéad G., Kakkar, Ajay K., Streiff, Michael B., Riess, Hanno, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Soff, Gerald A.
Publicado 2020

Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial

por Mones, Jodi V., Streiff, Michael B., Khorana, Alok A., Bendheim, Gemma A., Damaraju, C. V., Wildgoose, Peter, Burton, Paul, Riess, Hanno, Soff, Gerald A.
Publicado 2021

Rivaroxaban treatment of cancer‐associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience

por Soff, Gerald A., Mones, Jodi, Wilkins, Cy, Devlin, Sean, Haegler‐Laube, Eva, Wills, Jonathan, Sarasohn, Debra M., Juluru, Krishna, Singer, Michael, Miao, Yimei, Batista, Jeanette, Mantha, Simon
Publicado 2019

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia

por Soff, Gerald A., Miao, Yimei, Bendheim, Gemma, Batista, Jeanette, Mones, Jodi V., Parameswaran, Rekha, Wilkins, Cy R., Devlin, Sean M., Abou-Alfa, Ghassan K., Cercek, Andrea, Kemeny, Nancy E., Sarasohn, Debra M., Mantha, Simon
Publicado 2019

Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction

por Wang, Tzu-Fei, Khorana, Alok A, Agnelli, Giancarlo, Bloomfield, Dan, Bonaca, Marc P, Büller, Harry R, Connors, Jean M, Goto, Shinya, Jing, Zhi-Cheng, Kakkar, Ajay K, Khder, Yasser, Raskob, Gary E, Soff, Gerald A, Verhamme, Peter, Weitz, Jeffrey I, Carrier, Marc
Publicado 2023

Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation

por Scordo, Michael, Gilbert, Leah J., Hanley, Danielle M., Flynn, Jessica R., Devlin, Sean M., Nguyen, Linh K., Ruiz, Josel D., Shah, Gunjan L., Sauter, Craig S., Chung, David J., Landau, Heather J., Lahoud, Oscar B., Lin, Richard J., Dahi, Parastoo B., Perales, Miguel-Angel, Giralt, Sergio A., Soff, Gerald A.
Publicado 2022